LORBRENA® sNDA in Previously Untreated ALK-Positive Lung Cancer Accepted for Priority Review by U.S. FDA Pharmaceutical Investing
European Medicines Agency Validates Bristol Myers Squibb's Application for Zeposia for the Treatment of Ulcerative Colitis Biotech Investing
Myovant Sciences and Pfizer Announce Collaboration to Develop and Commercialize Relugolix in Oncology and Women's Health Pharmaceutical Investing
Algernon Pharmaceuticals Announces Last Patient Out in Multinational Phase 2b/3 Human Study of Ifenprodil for COVID-19 Biotech Investing
Lobe Sciences Announces Upsizing and First Closing of Non-brokered Private Placement Cannabis Investing News
